ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

NCI Revises Procedure for Contract Concept Review By Advisors

September 6, 1996

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993